100+ Research Topics in Pharmacy: 2026 Hot Topics

The field of pharmacy is currently navigating a period of profound technical and clinical realignment, making the selection of contemporary research topics in pharmacy essential for academic rigour and professional advancement. In 2026, the focus has moved beyond traditional batch manufacturing toward “continuous manufacturing” and the on-demand production of 3D-printed medications tailored to individual patient profiles. Simultaneously, pharmacists are assuming a central role in “precision medicine,” utilising pharmacogenomic data to eliminate trial-and-error prescribing. The global pharmaceutical landscape is also defined by a move toward “green pharmacy,” prioritising sustainable chemistry and the reduction of medical waste in the environment. This guide provides a comprehensive catalogue of ideas to help you examine how autonomous AI agents, digital therapeutics, and advanced molecular biology are redefining the modern pharmacy profession.

AI, Digital Transformation, and Agentic Pharmacy

1. Governing “Agentic AI” in Drug Discovery: Accountability for Autonomous Pipelines
   Investigate the administrative and legal hurdles of using AI agents that can independently plan and execute molecular simulations without human intervention.
2. The Role of AI-Powered Patient-Matching in Accelerating Clinical Trial Recruitment
   Analysing how machine learning models use electronic health records to identify ideal candidates for phase III trials with higher precision.
3. Predictive Analytics for Identifying Pharmaceutical Supply Chain Choke Points
   Researching the effectiveness of autonomous agents in forecasting ingredient shortages and rerouting logistics to prevent medication outages.
4. Managing “Automation Bias” in Hospital Pharmacy Dispensing Systems
   Evaluating the risk of pharmacists over-relying on automated picking robots and the subsequent impact on final verification accuracy.
5. Natural Language Processing (NLP) for Real-Time Pharmaceutical Jargon Translation
   Investigating the use of generative AI to provide patients with simplified, culturally sensitive summaries of their medication instructions.
6. The Ethics of AI-Generated Drug Formulations: Protecting Intellectual Property
   Analysing the legal challenges regarding the ownership of new chemical entities discovered through purely autonomous AI research cycles.
7. AI-Driven “Digital Twins” of Human Organs for In-Silico Pharmacokinetic Testing
   Evaluating the accuracy of virtual organ simulations in predicting drug absorption and metabolism before human testing begins.
8. Blockchain for Ensuring Data Integrity in Decentralised Clinical Trials
   Researching the use of decentralised ledgers to provide a tamper-proof record of patient-reported outcomes in remote pharmacy studies.
9. The Impact of “Small Language Models” (SLMs) on On-Site Pharmacy Information Services
   Investigating the benefits of running compact, locally-hosted AI models to assist pharmacists in checking complex drug interactions without cloud latency.
10. Inference Economics in 2026: Balancing the Cost of AI Models in Pharma R&D
    Analysing the management plans used by pharmaceutical firms to optimise the financial and energy costs of running massive AI simulations.

Personalised Medicine and Pharmacogenomics

11. Clinical Implementation of 3D-Printed Polypills: Improving Adherence in the Elderly
    Investigate the feasibility of combining multiple medications into a single, custom-shaped tablet using on-site pharmaceutical 3D printers.
12. The Impact of Pharmacogenomic Data on Reducing Adverse Drug Reactions (ADRs)
    Analysing the findings of 2026 pilots where universal genetic screening was used to tailor dosages for high-risk psychiatric medications.
13. Patient-Centred Bio-Inks: Developing Custom Drug Release Profiles via 3D Bioprinting
    Researching the chemical engineering of inks that allow for the precise timing of medication release based on an individual’s metabolism.
14. The Ethics of “Direct-to-Consumer” Pharmacogenomic Testing: Roles for the Pharmacist
    Evaluating the responsibility of community pharmacists in interpreting genetic reports for patients who have purchased private tests.
15. Managing “Polypharmacy” through Genome-Stratified Medication Reviews
    Investigating whether using a patient’s genetic profile allows for the safe reduction of the total number of medications prescribed to older adults.
16. The Role of “Epigenetic Clocks” in Determining Age-Related Dosage Adjustments
    Analysing whether biological age markers provide a superior baseline for prescribing compared to traditional chronological age.
17. Precision Dosing in Oncology: Moving beyond Body Surface Area (BSA) Models
    Researching the integration of real-time molecular markers to adjust chemotherapy intensity during the treatment cycle.
18. The Impact of Personalised Nutrition on the Efficacy of Oral Medications
    Investigating how individual microbiome profiles influence the absorption and effectiveness of common cardiovascular drugs.
19. Legal Hurdles for “On-Demand” Compounding via 3D Printing in Community Pharmacies
    Evaluating the regulatory requirements for verifying the safety and potency of medications produced outside of traditional factory environments.
20. Pharmacogenetics of Rare Diseases: Accelerating Diagnosis through Genomic Triage
    Researching the success of the 2026 Rare Diseases Action Plan in using drug response data to identify underlying genetic conditions.

Pharmaceutical Technology and Drug Delivery

21. Nanotechnology for Targeted Drug Delivery to the Blood-Brain Barrier
    Investigate the latest breakthroughs in using nanoparticles to transport large-molecule therapeutics into the central nervous system.
22. The Move toward “Continuous Manufacturing” in 2026: Efficiency and Quality
    Analysing the shift away from batch processing toward end-to-end production lines that improve the consistency of active ingredients.
23. Smart Wearable Patches for On-Demand Transdermal Insulin Delivery
    Researching the integration of glucose sensors with microneedle arrays to automate hormone administration for diabetic patients.
24. The Role of “Cryo-EM” in Visualising Protein-Ligand Interactions for Targeted Drugs
    Evaluating how high-resolution imaging at near-atomic levels allows for the design of more effective inhibitors for cancer cells.
25. Biodegradable Implantable Drug Delivery Systems: Reducing Surgical Removal Needs
    Investigating the use of advanced polymers that slowly release medication before safely dissolving into the human body.
26. The Impact of “Vibe Coding” on Pharmaceutical Software Security Standards
    Analysing the legal responsibility for failures in medical dispensing apps produced hastily using autonomous AI coding tools.
27. Aerosol Technology for High-Efficiency Lung Deposition in Asthma Care
    Researching why measuring the precise amount of drug reaching the lower respiratory tract is more vital than simple inhaler dosage.
28. Managing the Stability of Biological Products in “Cold-Chain” Logistics
    Evaluating the effectiveness of real-time IoT sensors in maintaining the integrity of vaccines during global transport.
29. The Use of Hydrogels in Regenerative Medicine and Chronic Wound Healing
    Investigating the development of “smart” gels that can respond to the local environment of a wound to release antibiotics only when needed.
30. Quantum Computing for Complex Molecular Simulations in 2026
    Analysing the potential for quantum systems to perform near-instantaneous calculations of drug-receptor binding energies.

Clinical Pharmacy and Patient Care

31. The Transition toward Community-Based Clinical Pharmacy: Moving Care from Hospitals
    Investigate the success of 2026 initiatives that allow pharmacists to manage chronic conditions like hypertension and diabetes in local hubs.
32. Pharmacist-Led Antimicrobial Stewardship (AMS) in Private Health Facilities
    Analysing the methods used by community practitioners to reduce the inappropriate prescribing of antibiotics in outpatient settings.
33. The Impact of “Digital Therapeutics” (DTx) on Medication Adherence and Mental Health
    Researching the effectiveness of software-based interventions prescribed alongside traditional pharmacotherapy for depression and anxiety.
34. Telepharmacy and the “Remote Dispensing” Model: Bridging the Rural Health Gap
    Evaluating the safety and patient satisfaction levels of virtual consultations paired with automated medication lockers.
35. Managing “Technostress” in Modern Pharmacy Teams: Impact on Patient Safety
    Investigating the psychological toll of navigating high-speed, automated treatment systems on clinicians and support staff.
36. The Role of Social Prescribing in Reducing Over-Prescribing of Antidepressants
    Analysing whether connecting patients to community groups and exercise leads to a measurable reduction in drug dependency.
37. Relationship-Based Practice in a High-Speed Digital Medical Environment
    Researching the tension between the “slow” work of building patient trust and the “fast” requirements of digital audits.
38. Managing the Impact of Long COVID on the Pharmaceutical Needs of the Elderly
    Investigating the persistent social and physical support required for patients experiencing chronic post-viral symptoms in 2026.
39. The Ethics of “Nudging” via Municipal AI: Encouraging Healthy Medication Habits
    Evaluating the moral boundaries of using digital signage and mobile notifications to influence public treatment compliance.
40. Pharmacist-Led Smoking Cessation via Chat: Evaluating Digital Support Channels
    Researching the effectiveness of automated, chat-based interventions in promoting long-term behavioural changes in patients.

Public Health, AMR, and Global Pharmacy

41. The “One Health” Approach to Antimicrobial Resistance: A 2026 Review
    Investigate the effectiveness of international treaties in limiting the use of critical antibiotics in agriculture to protect human health.
42. Green Pharmacy in 2026: Reducing the Environmental Impact of Medical Waste
    Analysing the success of national programmes designed to prevent the disposal of active pharmaceutical ingredients into public waterways.
43. Addressing Digital Inequalities in Pharmacy Services: Reaching the “Offline” Population
    Researching the strategies required to ensure that digital-first services do not alienate rural, elderly, or low-income communities.
44. The Impact of Global Supply Chain Fragmentation on the Availability of Essential Medicines
    Evaluating the risks of “friend-shoring” in pharmaceuticals and the resulting shortages of critical vaccines and antibiotics.
45. Sovereign AI for Real-Time Pathogen Tracking: Protecting National Bio-Security
    Investigating the development of national AI models to monitor the movement and evolution of infectious diseases within borders.
46. The Ethics of “Dynamic Pricing” in Global Medical Logistics and Aid Delivery
    Researching how algorithms that adjust shipping costs based on capacity influence the speed of delivering life-saving supplies.
47. Managing “Polycrisis”: Administrative Plans for Overlapping Systemic Health Shocks
    Analysing the preparedness of pharmaceutical agencies for the simultaneous impact of economic, environmental, and health crises.
48. The Role of “Institutional Storytelling” in Promoting Global Vaccination Equity
    Researching how narrative and transparent data can be used to convince wealthy nations to share medical resources with the Global South.
49. Modern Slavery in the Pharmaceutical Supply Chain: The Limits of Due Diligence
    Investigating the hurdles in holding multinational firms accountable for human rights abuses in the extraction of medical-grade minerals.
50. Health Sovereignty in the Global South: Resisting “Data Colonialism” in 2026
    Researching the efforts of developing nations to build their own medical data ecosystems to reduce reliance on Western tech giants.

Pharmacy Management, Policy, and Ethics

51. The Impact of “Grade Inflation” on the Perceived Quality of Pharmacy Graduates
    Investigate the administrative pressures in higher education and their effect on the clinical competence of newly qualified pharmacists.
52. Techno-Feudalism versus Digital Capitalism in the Management of Health Assets
    Analysing whether the control of medical data by a few firms constitutes a new form of non-territorial political authority in 2026.
53. The Role of “Challenge Networks” in Executive Pharmacy Coaching and Performance
    Evaluating whether encouraging constructive honesty within leadership teams leads to better decision-making than traditional hierarchies.
54. Managing the “Hidden Curriculum”: Institutional Oversight of Moral Learning in Pharmacy
    Researching how administrators monitor and influence the unwritten rules and norms that shape the professional experience.
55. The ROI of AI in Pharmaceutical Leadership: Measuring Financial and Qualitative Value
    Investigating the difficulties firms face in gauging the return on massive investments in generative AI tools for healthcare.
56. Violence against Women and Girls (VAWG): Impact of New Clinical Safety Duties
    Analysing the legal responsibility of pharmacies to proactively identify and support patients at risk of gender-based harm.
57. The Impact of Rising Real Estate Costs on the Geography of Pharmacy Recruitment
    Investigating how the affordability crisis in major cities is driving a shift in the distribution of frontline practitioners.
58. Sovereign Wealth Funds as Tools for National Health Infrastructure Development
    Evaluating the governance models required to ensure that state-owned funds are used for long-term medical benefit rather than political gain.
59. Managing the Impact of Climate Change on Professional Logistics and Pharmacy Safety
    Researching the redesign of public facilities for heat resilience and the protocols for maintaining operations during extreme weather.
60. The Impact of Brexit on UK Clinical Trial Integration: A Five-Year Review
    Investigating the divergence in regulatory standards and its effect on the speed of drug approval in the United Kingdom.

Pharmacology, Toxicology, and Therapeutic Advances

61. Neuroinflammation as a Foundational Marker for Cognitive Decline: New Pharmacology
    Investigate the link between systemic inflammation and the degradation of white-matter integrity in early-stage Alzheimer’s.
62. The Impact of “Smart Drugs” and Nootropics on Healthy Adolescent Brain Development
    Analysing the long-term cognitive and social consequences of the rising use of enhancers among students in 2026.
63. The Role of “Epigenetic Reprogramming” in Reversing Age-Related Memory Loss
    Researching the potential for cellular rejuvenation techniques to restore synaptic plasticity in the ageing brain.
64. Peptide Therapy beyond Weight Loss: The Mainstreaming of Growth-Hormone Secretagogues
    Evaluating the safety and efficacy of short-chain amino acids in boosting immune health and promoting tissue repair.
65. “Muscle as Medicine”: Sarcopenia as a Primary Marker for Metabolic Resilience
    Investigating the link between skeletal muscle mass and long-term resistance to insulin and chronic cardiovascular disease.
66. The “Ultra-Processed Food Reckoning”: Clinical Evidence for Microbiota Alteration
    Analysing how high consumption of synthetic additives increases low-grade chronic inflammation and cancer risk in 2026.
67. Insulin Resistance in Non-Obese Populations: Identifying Hidden Metabolic Risks
    Researching why a growing number of “lean” patients are presenting with the biomarkers of metabolic syndrome in 2026.
68. The Gut-Brain Axis: Managing Depression through Targeted Microbiome Interventions
    Evaluating the effectiveness of “psychobiotics” in altering neurotransmitter production to treat severe mood disorders.
69. Label-Free Imaging for Tracking Cancer Treatment Response in Individual Cells
    Investigating the use of mid-infrared optoacoustic microscopy (MiROM) to monitor how single cells react to therapy without using dyes.
70. The Impact of Hyperspectral Imaging on the Early Detection of Skin Cancers
    Analysing whether capturing data across hundreds of wavelengths provides a superior diagnostic tool compared to traditional photography.

Additional Emerging Topics for 2026

71. The Launch of the National Care Service: Navigating the 2026 Transition in Social Care
    Investigate the administrative hurdles of standardising care quality and pharmaceutical access across all local authorities.
72. The ROI of Preventative Pharmacy Interventions versus Late-Stage Crisis Hospitalisation
    Analysing the fiscal benefits of early pharmacist intervention in managing chronic disease compared to emergency admissions.
73. Pharmacy Professionals and the “Right to Disconnect”: Managing Digital Boundaries with Patients
    Evaluating the policies required to protect staff from out-of-hours contact in a hyper-connected digital health environment.
74. Techno-Feudalism in the Care Sector: Redefining Property in the Era of Digital Health
    Investigating whether the control of patient data by a few global platforms creates a new form of non-territorial authority.
75. The Impact of Global University Rankings on Local Pharmaceutical Research Priorities
    Analysing whether the pursuit of international prestige leads institutions to neglect regional vocational or community health needs.
76. Scaling Innovations in Public Health: Guidance and Toolkits for Low-Resource Settings
    Researching the effectiveness of international frameworks in helping pharmacies in developing nations adopt digital health solutions.
77. The 150-Day Clinical Trial Set-Up Target: Measuring UK Performance in March 2026
    Evaluating whether new national timeframes have successfully accelerated the recruitment of participants for pharmaceutical research.
78. Sovereign AI Units and the Protection of National Molecular Data Assets
    Investigating the development of locally-hosted AI models to ensure the security and privacy of sensitive citizen genetic records.
79. Role of “Challenge Networks” in Combating Groupthink in Medical and Pharmaceutical Research
    Evaluating whether encouraging constructive honesty within research teams leads to more resilient scientific outcomes.
80. Managing “Polycrisis”: Administrative Plans for Overlapping Systemic Pharmacy Shocks
    Analysing the preparedness of pharmaceutical agencies for the simultaneous impact of economic, environmental, and health crises.
81. The Use of AI-Simulated Patient Avatars for Training Junior Community Pharmacists
    Evaluating the effectiveness of replacing real interpersonal interactions with AI-driven virtual subjects in clinical coaching seminars.
82. Measuring the Environmental Footprint of Large-Scale Pharmaceutical 3D Printing
    Investigating the cumulative energy and chemical waste impact of moving from factory-based to pharmacy-based manufacturing.
83. The Role of Music and Spatial Audio in Enhancing Patient Recovery in Hospital Wards
    Researching the physiological and cognitive benefits of integrating auditory cues into the healing environment of modern clinics.
84. Advanced Bloodwork in 2026: Moving beyond Standard Panels to Inflammatory Cytokines
    Analysing the value of routine testing for specific biomarkers like IL-6 in predicting cardiovascular and metabolic shocks.
85. Managing “Hidden Hierarchies” of Social Power in Hospital Administrative Teams
    Investigating how unwritten rules and social networks influence the execution of pharmacy policy in supposedly neutral bureaucracies.
86. The Impact of “Vibe Coding” on Software Liability for Pharmacy Dispensing Systems
    Evaluating the legal responsibility for errors in healthcare software produced hastily using autonomous AI development tools.
87. Addressing Digital Poverty as a Driver of Poor Medication Adherence in 2026
    Researching how limited access to devices and connectivity prevents vulnerable patients from using digital therapy tools.
88. The Role of “Sovereign AI” in Protecting National Social Welfare and Health Data
    Analysing the move toward state-managed AI infrastructure to safeguard sensitive citizen records from commercial exploitation.
89. Evaluating the Success of the 10-Year Health Plan for England: Joined-Up Pharmacy Care
    Investigating whether the structural integration of pharmacies and the NHS has led to improved outcomes for chronic patients.
90. Ethics of “Nudging” Citizens toward Healthy Habits via Municipal and Pharmacy AI
    Evaluating the moral boundaries of using digital persuasion to influence public recycling, exercise, and treatment compliance.
91. The Impact of Political Polarisation on the Internal Culture of Pharmacy Agencies
    Analysing how differing social values among staff affect the implementation of inclusive and anti-oppressive healthcare policies.
92. Managing “Automation Paradox”: The Decline of Critical Thinking in Junior Pharmacy Staff
    Researching the supervisory adjustments required to ensure new staff do not over-rely on automated dispensing and checks.
93. Pharmacists as “Digital Security Specialists”: A New Core Skill for Safe Practice in 2026
    Investigating the expansion of the pharmaceutical role to include the assessment of digital risks and cyber-resilience for patients.
94. Evaluating the Impact of the March 2026 Deadline for Multi-Agency Child Protection
    Analysing the success of new national standards requiring closer collaboration between pharmacies, schools, and social services.
95. The Role of “Eco-Social Justice” in Reshaping the Global Pharmacy and Health Agenda
    Evaluating the integration of environmental rights and resource equity into the core mission of the global pharmacy profession.
96. Impact of Rising Real Estate Costs on the Geography of Community Pharmacy Recruitment
    Investigating how the affordability crisis in major cities is driving a shift in the distribution of frontline pharmaceutical practitioners.
97. Managing the Impact of Climate Change on Professional Logistics and Pharmacy Safety
    Researching the redesign of pharmacy facilities for heat resilience and the protocols for maintaining operations during extreme weather.
98. The Ethics of “Dynamic Pricing” in Medical Logistics for Humanitarian Aid Delivery
    Evaluating the impact of algorithms that adjust shipping costs based on capacity on the delivery of life-saving medicines to conflict zones.
99. Techno-Feudalism versus Digital Capitalism: Redefining Property in the Health Sector
    Analysing whether the control of health platforms by a few firms constitutes a new form of non-territorial authority in 2026.
100. Managing the “Hidden Curriculum”: Oversight of Moral Learning in the Workforce
     Investigating how administrators monitor and influence the unwritten rules and norms that shape the professional pharmacy experience.
101. The Impact of Global University Rankings on Local Pharmacy Training Priorities
     Researching whether the pursuit of international prestige leads to the neglect of regional community health or vocational needs.

How to Use These Research Topics in Pharmacy

Selecting a subject is only the first step in your academic journey. To get the most out of this list, we recommend following these steps to refine your chosen idea:

• Narrow the Scope: Many of the topics listed here are broad. Once you select one, try to focus on a specific patient demographic (for example, adolescents or the elderly) or a specific technological constraint (for example, on-site 3D printing versus industrial continuous manufacturing) to make your research more manageable.
• Conduct a Preliminary Literature Review: Before committing to a topic, check academic and professional databases like PubMed (MEDLINE), ScienceDirect, or the International Pharmaceutical Federation (FIP) to ensure there is enough existing data to support your study.
• Identify Your Methodology: Decide early on whether your research will be qualitative (interviews with practitioners, case studies) or quantitative (analysing large-scale dispensing datasets, clinical trial statistics, or lab-based experiments).
• Check for Ethical Constraints: If your topic involves the collection of sensitive patient data, genetic samples, or speaking to staff about institutional stress, ensure you can obtain full ethical approval and the necessary data protection clearances before you begin.